Leerink Partnrs Has Pessimistic Outlook of ELDN Q4 Earnings
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Research analysts at Leerink Partnrs lowered their Q4 2024 earnings estimates for Eledon Pharmaceuticals in a report released on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($0.32) per share for the quarter, down from their prior estimate of ($0.16). […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Research analysts at Leerink Partnrs lowered their Q4 2024 earnings estimates for Eledon Pharmaceuticals in a report released on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($0.32) per share for the quarter, down from their prior estimate of ($0.16). […]
